The National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential medications. This initiative could shield retail chemists and hospitals from legal repercussions concerning pricing infractions. Manufacturers are likely to challenge the proposal, alleging it is uncompromising and unjust. Previously, substantial penalties have been levied against drugmakers for such transgressions.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.